Cargando…

Serum Osteoprotegerin Is an Independent Marker of Metabolic Complications in Non-DialysisDependent Chronic Kidney Disease Patients

Background: Osteoprotegerin (OPG) belongs to the tumour necrosis factor superfamily and is known to accelerate endothelial dysfunction and vascular calcification. OPG concentrations are elevated in patients with chronic kidney disease. The aim of this study was to investigate the association between...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rymarz, Aleksandra, Romejko, Katarzyna, Matyjek, Anna, Bartoszewicz, Zbigniew, Niemczyk, Stanisław
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8538217/ https://www.ncbi.nlm.nih.gov/pubmed/34684610 http://dx.doi.org/10.3390/nu13103609

Ejemplares similares

Serum Osteoprotegerin Is an Independent Marker of Left Ventricular Hypertrophy, Systolic and Diastolic Dysfunction of the Left Ventricle and the Presence of Pericardial Fluid in Chronic Kidney Disease Patients
por: Romejko, Katarzyna, et al.
Publicado: (2022)

Relationships between Sclerostin, Leptin and Metabolic Parameters in Non-Dialysis Chronic Kidney Disease Males
por: Romejko, Katarzyna, et al.
Publicado: (2022)

Left Ventricular Diastolic Dysfunction in Chronic Kidney Disease Patients Not Treated with Dialysis
por: Romejko, Katarzyna, et al.
Publicado: (2022)

Resistin Contribution to Cardiovascular Risk in Chronic Kidney Disease Male Patients
por: Romejko, Katarzyna, et al.
Publicado: (2023)

Testosterone Deficiency as One of the Major Endocrine Disorders in Chronic Kidney Disease
por: Romejko, Katarzyna, et al.
Publicado: (2022)

Protein energy-wasting associated with nephrotic syndrome – the comparison of metabolic pattern in severe nephrosis to different stages of chronic kidney disease
por: Matyjek, Anna, et al.
Publicado: (2020)

Advanced Chronic Kidney Disease is a Strong Predictor of Hypogonadism and is Associated with Decreased Lean Tissue Mass
por: Skiba, Ryszard, et al.
Publicado: (2020)

Impaired Kidney Function Associated with Increased Risk of Side Effects in Patients with Small Vessel Vasculitis Treated with Rituximab as an Induction Therapy
por: Rymarz, Aleksandra, et al.
Publicado: (2021)

Testosterone Replacement Therapy in Chronic Kidney Disease Patients
por: Skiba, Ryszard, et al.
Publicado: (2022)

Comparison of Skinfold Thicknesses and Bioimpedance Spectroscopy to Dual-Energy X-Ray Absorptiometry for the Body Fat Measurement in Patients With Chronic Kidney Disease
por: Rymarz, Aleksandra, et al.
Publicado: (2017)

Anti-Xa Activity of Enoxaparin for Prevention of Venous Thromboembolism in Severe Nephrotic Syndrome—A Single Center Prospective Study
por: Matyjek, Anna, et al.
Publicado: (2021)

Is Free Testosterone Concentration a Prognostic Factor of Survival in Chronic Renal Failure (CRF)?
por: Niemczyk, Stanisław, et al.
Publicado: (2015)

Melatonin Treatment in Kidney Diseases
por: Markowska, Magdalena, et al.
Publicado: (2023)

Low Free Triiodothyronine as a More Sensitive Predictor of Survival Than Total Testosterone among Dialysis Men
por: Leśniak, Ksymena, et al.
Publicado: (2023)

First year survival of patients on maintenance dialysis treatment in Poland
por: Brodowska-Kania, Dorota, et al.
Publicado: (2015)

The complex treatment including rituximab in the Management of Catastrophic Antiphospholid Syndrome with renal involvement
por: Rymarz, Aleksandra, et al.
Publicado: (2018)

Testosterone Deficiency and Nutritional Parameters as Predictors of All-Cause Mortality among Male Dialysis Patients
por: Leśniak, Ksymena, et al.
Publicado: (2022)

Visceral Adipose Tissue is Associated with Insulin Resistance in Hemodialyzed Patients
por: Giers, Kinga, et al.
Publicado: (2015)

Homeostatic model assessment indices in evaluation of insulin resistance and secretion in hemodialysis patients
por: Niemczyk, Stanisław, et al.
Publicado: (2013)

The significance of metalloproteinase 3 (MMP-3), chemokine CXC ligand 13 (CXCL-13) and complement component C5a in different stages of ANCA associated vasculitis
por: Rymarz, Aleksandra, et al.
Publicado: (2021)

The Review of Current Knowledge on Neutrophil Gelatinase-Associated Lipocalin (NGAL)
por: Romejko, Katarzyna, et al.
Publicado: (2023)

Changes of Hemodynamic Parameters after Intradialytic Glucose Injection
por: Niemczyk, Longin, et al.
Publicado: (2023)

Assessment of the correlation of commonly used laboratory tests with clinical activity, renal involvement and treatment of systemic small-vessel vasculitis with the presence of ANCA antibodies
por: Mosakowska, Magdalena, et al.
Publicado: (2021)

Application of dynamic optimisation for planning a haemodialysis process
por: Stecz, Wojciech, et al.
Publicado: (2019)

Noninfectious, Severe Cryoglobulinemic Vasculitis with Renal Involvement – Safety and Efficacy of Long-Term Treatment with Rituximab
por: Leśniak, Ksymena, et al.
Publicado: (2021)

Heart Metastases of Clear Cell Renal Cell Carcinoma
por: Romejko, Katarzyna, et al.
Publicado: (2023)

Low lean tissue mass can be a predictor of one-year survival in hemodialysis patients
por: Rymarz, Aleksandra, et al.
Publicado: (2018)

Ocular Involvement of Granulomatosis with Polyangiitis
por: Byszewska, Anna, et al.
Publicado: (2023)

Cardiovascular Response to Intravenous Glucose Injection during Hemodialysis with Assessment of Entropy Alterations
por: Niemczyk, Longin, et al.
Publicado: (2022)

Age-related differences in the quality of life in end-stage renal disease in patients enrolled in hemodialysis or continuous peritoneal dialysis
por: Laudański, Krzysztof, et al.
Publicado: (2013)

Serum osteoprotegerin level is positively associated with peripheral artery disease in patients with peritoneal dialysis
por: Lin, Wei-Chen, et al.
Publicado: (2020)

Serum osteoprotegerin is associated with pulse pressure in kidney transplant recipients
por: Nemeth, Zsofia K., et al.
Publicado: (2015)

Vancomycin dosing in patients undergoing maintenance hemodialysis
por: Rymarz, Aleksandra, et al.
Publicado: (2014)

Nutritional Status, Selected Nutrients Intake and Their Relationship with the Concentration of Ghrelin and Adiponectin in Patients with Diabetic Nephropathy
por: Boniecka, Iwona, et al.
Publicado: (2021)

Canonical Wnt signaling inhibits osteoclastogenesis independent of osteoprotegerin
por: Albers, Joachim, et al.
Publicado: (2013)

Osteoprotegerin as a Marker of Atherosclerosis in Diabetic Patients
por: Augoulea, Areti, et al.
Publicado: (2013)

Bone Turnover Markers and Osteoprotegerin in Uncomplicated Pregnancy
por: Styczynska, Hanna, et al.
Publicado: (2009)

The Correlation of Serum Osteoprotegerin with Non-Traditional Cardiovascular Risk Factors and Arterial Stiffness in Patients with Pre-Dialysis Chronic Kidney Disease: Results from the KNOW-CKD Study
por: Chae, Seung Yun, et al.
Publicado: (2018)

Osteoprotegerin is a marker of cardiovascular mortality in patients with chronic kidney disease stages 3–5
por: Marques, Gustavo Lenci, et al.
Publicado: (2021)

Osteoprotegerin (OPG) as a biomarker for diabetic cardiovascular complications
por: Bjerre, Mette
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_e5kc1skqfeglqp8tv86so0s33a